Grossman G.Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis. J Steroid Biochem1989 ; 34: 241-51.
3.
Parke LAPregnancy and systemic lupus erythematosus. In: Lahita RG, ed. Systemic Lupus Erythematosus . Edinburgh: Churchill Livingstone , 1992: 543-59.
4.
Julkunen HA, Kaaja R., Friman C.Contraceptive practise in women with systemic lupus erythematosus . Br J Rheum1993; 32: 227-30.
5.
Jungers P., Dougados M., Pelissier C. et al. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum1982; 25: 618-23.
6.
Julkunen HAOral contraceptives in systemic lupus erythematosus: side-effects and influence on the activity of SLE. Scand J Rheum1991 ; 20: 427-33.
Devor M., Barrett-Connor E., Eenvall M., Feigal D., Ramsdell J.Estrogen replacement therapy and the risk of venous thrombosis. Am J Med1992; 92: 275-82.
Arden NK, Lloyd ME, Spector TD, Hughes Grv.The safety of hormone replacement therapy in systemic lupus erythematosus . Lupus1994 (in press).
11.
Petri M., Perez-Gutthann S., Spence D., Hochberg M.Risk factors for coronary artery disease in patients with systemic lupus erythematosus . Am J Med1992; 93: 513-19.
12.
Stampfer MJ , Coldidz GA, Willett WC et al. Postmenopausal estrogen therapy and cardiovascular disease. New Engl J Med1991 ; 325: 756-62.
Kelsey JL, Hoffman S.Risk factors for hip fracture. New Engl J Med1987; 316: 404-6.
15.
Hall GM, Daniels M., Wiltshire P., O'Gara C., Spector TDThe effects of estrogen replacement therapy and calcium on bone loss in rheumatoid arthritis: a 2 year prospective study. Arthritis Rheum1993; 36: S50 (abstract 72).